2023 Q2 Form 10-Q Financial Statement

#000162828023017703 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $12.62M $1.498M $5.160M
YoY Change 120.68% -56.69% 20.39%
Cost Of Revenue $9.162M $970.0K $2.767M
YoY Change 216.01% -42.62% 55.18%
Gross Profit $3.454M $528.0K $2.393M
YoY Change 22.59% -70.14% -4.39%
Gross Profit Margin 27.38% 35.25% 46.38%
Selling, General & Admin $7.374M $3.428M $3.619M
YoY Change 114.16% -1.81% -25.19%
% of Gross Profit 213.49% 649.24% 151.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $767.0K $7.000K $399.0K
YoY Change 8957.63% -98.25% -1.31%
% of Gross Profit 22.21% 1.33% 16.67%
Operating Expenses $7.374M $3.428M $3.633M
YoY Change 114.16% -11.82% -24.9%
Operating Profit -$3.920M -$2.900M -$1.240M
YoY Change 526.49% 36.87% -46.89%
Interest Expense -$2.254M -$1.174M -$1.768M
YoY Change 151.43% 3225.78% 5801.2%
% of Operating Profit
Other Income/Expense, Net -$2.151M -$896.0K $105.0K
YoY Change 282.87% 11.4% -119.16%
Pretax Income -$6.071M -$3.796M -$2.903M
YoY Change 411.23% 79.32% -0.34%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.071M -$3.796M -$2.905M
YoY Change 411.23% 79.32% -0.27%
Net Earnings / Revenue -48.12% -253.4% -56.3%
Basic Earnings Per Share -$0.04 -$0.03
Diluted Earnings Per Share -$0.04 -$0.03 -$0.02
COMMON SHARES
Basic Shares Outstanding 171.2M shares 149.6M shares 149.2M shares
Diluted Shares Outstanding 166.8M shares 149.7M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.350M $784.0K $316.0K
YoY Change 702.99% 36.28% -59.56%
Cash & Equivalents $3.400M $784.0K $316.0K
Short-Term Investments
Other Short-Term Assets $1.423M $408.0K $600.0K
YoY Change 85.77% -53.92% -33.68%
Inventory
Prepaid Expenses $1.610M $595.0K $737.0K
Receivables $15.23M $1.264M $3.585M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $20.00M $2.456M $4.501M
YoY Change 326.45% -41.0% -14.39%
LONG-TERM ASSETS
Property, Plant & Equipment $214.0K $38.00K $40.00K
YoY Change 296.72% -35.14% -38.58%
Goodwill $20.94M $19.65M $19.65M
YoY Change 6.57% 0.0%
Intangibles $19.56M $4.124M
YoY Change
Long-Term Investments
YoY Change
Other Assets $187.0K $187.0K $137.0K
YoY Change -21.16% -56.76% -43.55%
Total Long-Term Assets $41.23M $24.35M $24.70M
YoY Change 58.51% -5.67% -6.11%
TOTAL ASSETS
Total Short-Term Assets $20.00M $2.456M $4.501M
Total Long-Term Assets $41.23M $24.35M $24.70M
Total Assets $61.23M $26.80M $29.20M
YoY Change 99.44% -10.57% -7.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.14M $7.660M $8.585M
YoY Change 30.72% -9.41% 1.48%
Accrued Expenses $736.0K $494.0K $411.0K
YoY Change -74.06% -88.79% -89.08%
Deferred Revenue $4.863M $974.0K $737.0K
YoY Change 679.79% -36.6%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.123M $7.767M $4.928M
YoY Change 1429.6% 255.26%
Total Short-Term Liabilities $29.01M $19.44M $17.85M
YoY Change 65.8% 35.8% -22.62%
LONG-TERM LIABILITIES
Long-Term Debt $53.06M $24.86M $25.10M
YoY Change 139.16% 2.75% 64.95%
Other Long-Term Liabilities $276.0K $304.0K $319.0K
YoY Change -60.08%
Total Long-Term Liabilities $53.34M $25.16M $25.42M
YoY Change 133.14% 4.01% 67.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.01M $19.44M $17.85M
Total Long-Term Liabilities $53.34M $25.16M $25.42M
Total Liabilities $82.35M $44.60M $43.27M
YoY Change 103.95% 15.83% 13.02%
SHAREHOLDERS EQUITY
Retained Earnings -$124.1M -$118.1M -$114.3M
YoY Change 13.39% 7.68%
Common Stock $1.721M $1.506M $1.504M
YoY Change 14.75% 0.39%
Preferred Stock
YoY Change
Treasury Stock (at cost) $220.0K $220.0K $220.0K
YoY Change 0.07% 0.07%
Treasury Stock Shares 825.2K shares 825.2K shares 825.2K shares
Shareholders Equity -$21.12M -$17.80M -$14.07M
YoY Change
Total Liabilities & Shareholders Equity $61.23M $26.80M $29.20M
YoY Change 99.44% -10.57% -7.49%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$6.071M -$3.796M -$2.905M
YoY Change 411.23% 79.32% -0.27%
Depreciation, Depletion And Amortization $767.0K $7.000K $399.0K
YoY Change 8957.63% -98.25% -1.31%
Cash From Operating Activities -$2.563M -$1.000M -$24.00K
YoY Change 93.58% -19.46% -98.46%
INVESTING ACTIVITIES
Capital Expenditures -$1.000K $5.000K $14.00K
YoY Change -73.82% 440.54%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $1.000K -$5.000K -$14.00K
YoY Change -126.18% -640.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.127M $1.500M -58.00K
YoY Change 338.31% 44.84% -102.82%
NET CHANGE
Cash From Operating Activities -2.563M -$1.000M -24.00K
Cash From Investing Activities 1.000K -$5.000K -14.00K
Cash From Financing Activities 5.127M $1.500M -58.00K
Net Change In Cash 2.565M $468.0K -96.00K
YoY Change -1722.39% -119.08%
FREE CASH FLOW
Cash From Operating Activities -$2.563M -$1.000M -$24.00K
Capital Expenditures -$1.000K $5.000K $14.00K
Free Cash Flow -$2.562M -$1.005M -$38.00K
YoY Change 94.07% -19.06% -97.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001568385
CY2023Q1 bmtm Service Agreement Period
ServiceAgreementPeriod
P5Y0M0D
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-54887
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Bright Mountain Media, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2977890
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6400 Congress Avenue
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2050
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33487
CY2023Q1 dei City Area Code
CityAreaCode
561
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
998-2440
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
171211454 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
784000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
316000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1264000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3585000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
408000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
600000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
2456000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4501000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4124000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4510000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
19645000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
19645000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
352000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
367000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
187000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
137000 usd
CY2023Q1 us-gaap Assets
Assets
26802000 usd
CY2022Q4 us-gaap Assets
Assets
29200000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8835000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10317000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1758000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1838000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
974000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
737000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19439000 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150634636 shares
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17851000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
304000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
319000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
44599000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
43271000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
324000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
324000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150444636 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149809461 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149619461 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1506000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1504000 usd
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
220000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
220000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98851000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98797000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118065000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-114269000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
131000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
117000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-17797000 usd
CY2022Q1 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-14071000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26802000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29200000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1498000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3460000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
970000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1728000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
528000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1732000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3428000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3851000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2900000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2119000 usd
CY2023Q1 bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
0 usd
CY2022Q1 bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
842000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
278000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
6000 usd
CY2022Q1 us-gaap Interest Expense Other
InterestExpenseOther
0 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-896000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3796000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2117000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3796000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2117000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3796000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2118000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3782000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2118000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149708905 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149708905 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149101377 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149101377 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-14071000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3796000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31000 usd
CY2023Q1 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
14000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-17797000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6724000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2117000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-1000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
279000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-8534000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3796000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2117000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
7000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
3000 usd
CY2023Q1 bmtm Noncash Interest Expense
NoncashInterestExpense
789000 usd
CY2022Q1 bmtm Noncash Interest Expense
NoncashInterestExpense
0 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
14000 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
305000 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
280000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
386000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
396000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
29000 usd
CY2023Q1 bmtm Stock Compensation For Oceanside Shares
StockCompensationForOceansideShares
0 usd
CY2022Q1 bmtm Stock Compensation For Oceanside Shares
StockCompensationForOceansideShares
117000 usd
CY2023Q1 bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
0 usd
CY2022Q1 bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
842000 usd
CY2023Q1 bmtm Common Stock Issued For Services Rendered
CommonStockIssuedForServicesRendered
31000 usd
CY2022Q1 bmtm Common Stock Issued For Services Rendered
CommonStockIssuedForServicesRendered
0 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-188000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
271000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2509000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-592000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-142000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-114000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
1000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1471000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-463000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-96000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
237000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-302000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1031000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1363000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 bmtm Payments For Proceeds From Dividend Payments
PaymentsForProceedsFromDividendPayments
0 usd
CY2022Q1 bmtm Payments For Proceeds From Dividend Payments
PaymentsForProceedsFromDividendPayments
-1000 usd
CY2023Q1 bmtm Proceeds From Repayments Of Notes Receivable
ProceedsFromRepaymentsOfNotesReceivable
0 usd
CY2022Q1 bmtm Proceeds From Repayments Of Notes Receivable
ProceedsFromRepaymentsOfNotesReceivable
6000 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1500000 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1400000 usd
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
250000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1500000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1157000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
468000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-206000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
316000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
781000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
784000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
575000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
789000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
0 usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
162000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118100000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1400000 usd
CY2023Q1 bmtm Working Capital Deficit
WorkingCapitalDeficit
17000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
784000 usd
CY2023Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
338000 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
66000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
784000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
316000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of our consolidated financial statements as well as reported amounts of revenue and expenses during the periods presented. Our consolidated financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant estimates included in the accompanying consolidated financial statements include, valuation of goodwill and intangible assets, estimates of amortization period for intangible assets, estimates of depreciation period for property and equipment, the valuation of equity-based transactions, valuation of the Center Lane Senior Secured Facility carrying value regarding debt modification or extinguishment,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and the valuation allowance on deferred tax assets.</span></div>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of Credit Risk<div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject us to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with high credit-quality financial institutions. Such deposits may be in excess of federally insured limits. In addition, the Company maintains various bank accounts in Thailand and Israel, with some level of insurance. We perform periodic evaluations of the relative credit standing of the financial institutions. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We perform credit evaluations of our customers’ financial condition and require no collateral from our customers. We maintain an allowance for doubtful accounts receivable based upon the expected collectability of accounts receivable balances.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company generates revenue through sales of advertising services which generate revenue from advertisements placed on the Company’s owned and managed sites, as well as from advertisements placed on partner websites, for which the Company earns a share of the revenue.</span></div>
CY2023Q1 bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
0 customer
CY2022Q1 bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
1 customer
CY2023Q1 bmtm Number Of Customers Exceeding10 Receivable
NumberOfCustomersExceeding10Receivable
1 customer
CY2022 bmtm Number Of Customers Exceeding10 Receivable
NumberOfCustomersExceeding10Receivable
1 customer
CY2023Q1 bmtm Number Of Vendors Exceeding10 Revenue
NumberOfVendorsExceeding10Revenue
1 vendor
CY2022 bmtm Number Of Vendors Exceeding10 Revenue
NumberOfVendorsExceeding10Revenue
2 vendor
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Reclassification</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, reclassification of certain accounts has been made to previously reported amounts to conform to their treatment to the current period. Specifically, the Company identified a reclassification of commissions from general and administrative expenses to cost of revenue on the consolidated statements of operations, reclassification between note receivable to prepaid expense and other current assets, website acquisition assets to intangible asset, as well as a reclassification between accrued expenses to other liabilities on the consolidated balance sheets. These reclassifications had no impact on the previously reported net loss for the three months ended March 31, 2022.</span></div>
CY2023Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
1251000 usd
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
3447000 usd
CY2023Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
388000 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
724000 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1639000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4171000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
375000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
586000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1264000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3585000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-188000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
271000 usd
CY2023Q1 bmtm Prepaid Consulting Service Agreements
PrepaidConsultingServiceAgreements
190000 usd
CY2022Q4 bmtm Prepaid Consulting Service Agreements
PrepaidConsultingServiceAgreements
285000 usd
CY2023Q1 us-gaap Deposits Assets
DepositsAssets
87000 usd
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
137000 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
318000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
315000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
595000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
737000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
187000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
137000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
408000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
600000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
396000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
389000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
358000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
349000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3000 usd
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y4M24D
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4124000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4510000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
386000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
396000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1157000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1542000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
781000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
147000 usd
CY2023Q1 bmtm Finite Lived Intangible Asset Expected Amortization After Year Three
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearThree
497000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4124000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
19645000 usd
CY2023Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 usd
CY2023Q1 us-gaap Goodwill
Goodwill
19645000 usd
CY2020Q2 bmtm Repayment Of Loans Percentage
RepaymentOfLoansPercentage
0.025
CY2023Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
250000 usd
CY2023Q1 bmtm Repayment Of Loans Percentage
RepaymentOfLoansPercentage
0.025
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7660000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8585000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
389000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
380000 usd
CY2023Q1 bmtm Publisher Cost Current
PublisherCostCurrent
204000 usd
CY2022Q4 bmtm Publisher Cost Current
PublisherCostCurrent
559000 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
413000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
677000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
169000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
116000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8835000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10317000 usd
CY2022Q1 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
0 usd
CY2023Q1 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
0 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
7696000 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
4860000 usd
CY2023Q1 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
24856000 usd
CY2022Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
25101000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
32552000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
29961000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2921000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3148000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
35473000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
33109000 usd
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
33109000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
26334000 usd
CY2023Q1 bmtm Debt Instruments Additional Draw
DebtInstrumentsAdditionalDraw
1500000 usd
CY2022Q4 bmtm Debt Instruments Additional Draw
DebtInstrumentsAdditionalDraw
3050000 usd
CY2023Q1 bmtm Debt Instrument Exit And Other Fee
DebtInstrumentExitAndOtherFee
75000 usd
CY2022Q4 bmtm Debt Instrument Exit And Other Fee
DebtInstrumentExitAndOtherFee
621000 usd
CY2023Q1 bmtm Debt Instrument Interest Capitalized
DebtInstrumentInterestCapitalized
789000 usd
CY2022Q4 bmtm Debt Instrument Interest Capitalized
DebtInstrumentInterestCapitalized
3104000 usd
CY2023Q1 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
2364000 usd
CY2022Q4 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
6775000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
35473000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
33109000 usd
CY2023Q1 bmtm Debt Instrument Number Of Amendments
DebtInstrumentNumberOfAmendments
16 amendment
CY2023Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
9675000 usd
CY2023Q1 bmtm Line Of Credit Facility Agency Fee
LineOfCreditFacilityAgencyFee
105000 usd
CY2023Q1 bmtm Line Of Credit Facility Exit Fee
LineOfCreditFacilityExitFee
3775000 usd
CY2023Q1 us-gaap Shares Issued
SharesIssued
12650000000 shares
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6000000 usd
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
500000 usd
CY2023Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
862000 usd
CY2022Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
558000 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
301000 usd
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
277000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1163000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
835000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1498000 usd
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.015
CY2020Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.18
CY2022Q3 bmtm Legal Settlement Period
LegalSettlementPeriod
P50M
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1498000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3460000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6517660 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3460000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
737000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1162000 usd
CY2023Q1 bmtm Deferred Revenue Invoice Amount
DeferredRevenueInvoiceAmount
410000 usd
CY2022 bmtm Deferred Revenue Invoice Amount
DeferredRevenueInvoiceAmount
588000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
173000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1013000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
974000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
737000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.12
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
425000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.17
CY2023Q1 bmtm Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2
P9Y2M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
442500 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6500160 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.13
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1069295 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.50
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
5430865 shares
CY2023Q1 bmtm Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageExercisePrice
0.06
CY2023Q1 bmtm Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm1
P9Y2M12D
CY2023Q1 bmtm Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedIntrinsicValue1
0 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
200847 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.99
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0361
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 bmtm Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2022Q1 bmtm Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
352000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
358000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
54000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
40000 usd
CY2022Q1 us-gaap Payments For Rent
PaymentsForRent
48000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
352000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
367000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
54000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
304000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
319000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
358000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
357000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
54000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
174253 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
174253 shares
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
279000 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
35998316 shares
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
26692000 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150634636 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149984636 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149809461 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149159461 shares
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3796000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2117000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3796000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2118000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149708905 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149708905 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149101377 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149101377 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 bmtm Debt Instrument Number Of Amendments
DebtInstrumentNumberOfAmendments
16 amendment
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd

Files In Submission

Name View Source Status
bmtm-20230331_def.xml Edgar Link unprocessable
bmtm-20230331_cal.xml Edgar Link unprocessable
0001628280-23-017703-index-headers.html Edgar Link pending
0001628280-23-017703-index.html Edgar Link pending
0001628280-23-017703.txt Edgar Link pending
0001628280-23-017703-xbrl.zip Edgar Link pending
bmtm-20230331.htm Edgar Link pending
bmtm-20230331.xsd Edgar Link pending
bmtm-20230331_g1.jpg Edgar Link pending
bmtm-2023x0331x10qxexx311.htm Edgar Link pending
bmtm-2023x0331x10qxexx312.htm Edgar Link pending
bmtm-2023x0331x10qxexx321.htm Edgar Link pending
bmtm-2023x0331x10qxexx322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
bmtm-20230331_lab.xml Edgar Link unprocessable
bmtm-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bmtm-20230331_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending